Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gda?sk
Clinical trial register · Poland

Clinical Trials in Gda?sk, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 61 Krakow 42 Bydgoszcz 37 Lublin 30 Gda?sk 28
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw61 Krakow42 Bydgoszcz37 Lublin30 Gda?sk28
All 79 locations
Target enrolment
to

Trials with a site in Gda?sk

28 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Hoffmann-La Roche
Phase 3
380
Krakow, Gda?sk, Późna, Szczecin, Warsaw, Wroc?aw
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 2
360
Poznan, Rzeszw, Katowice, ?ory, ?ód?, Bydgoszcz, Gda?sk, Kielce
2026-03-10
Recruiting
Hoffmann-La Roche
Phase 3
900
Bia?ystok, Bydgoszcz, Gda?sk, Katowice, Krakow, Lublin, Oświęcim, Rzeszów
2025-11-24
Recruiting
Hoffmann-La Roche
Phase 3
80,000
?ory, ?ód?, B?dzin, Bia?ystok, Bydgoszcz, Gda?sk, Gdansk, Katowice
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
230
Bydgoszcz, Gda?sk, Gdynia, Gliwice, Konin, Koszalin, Późna, Warsaw
2023-09-08
Active, closed
Hoffmann-La Roche
Phase 2/3
97
?ód?, Gda?sk, Późna, Warsaw
2022-06-02
Active, closed
Hoffmann-La Roche
Phase 3
188
Gda?sk, Późna, Warsaw
2022-05-19
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Bydgoszcz, Gda?sk, Katowice, Krakow, Lodz, Lublin, Olsztyn, Plewiska
2022-05-03
Active, closed
Hoffmann-La Roche
Phase 3
660
Gda?sk, Krakow, Olsztyn, Otwock, Poznan, Warsaw
2021-11-18
Active, closed
Hoffmann-La Roche
Phase 2
586
?ód?, Bydgoszcz, Gda?sk, Krakow, Lublin, Rzeszów, Warsaw
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
190
Bydgoszcz, Gda?sk, Lublin, Skórzewo, Warsaw
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 2
23
Gda?sk, Późna, Warsaw
2020-01-09
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Bydgoszcz, Wroclaw, Lublin, Rzeszów, Rybnik, Bia?ystok, Gda?sk, Grodzisk Mazowiecki
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 2
26
Gda?sk
2019-08-07
Active, closed
Hoffmann-La Roche
Phase 3
257
Gda?sk, Krakow, Olsztyn, Poznan
2018-08-16
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Gda?sk, Olsztyn, Poznan, Warsaw
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 2
534
Gda?sk, Gliwice, Późna, Warsaw
2015-11-19
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/gda-sk

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies with a site in Gda?sk that also match the filters currently applied.

How many clinical trials are recruiting in Gda?sk?

11 of the 28 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gda?sk), 28 studies
PhaseStudiesRecruitingShare
Phase 316757.1%
Phase 25117.9%
Phase 1/23210.7%
Phase 2/3207.1%
Phase 1113.6%
Phase 4103.6%

Most active sponsors

Lead sponsors with the most studies (Gda?sk)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche2811
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.